glp-1 agonists New Guidelines for Type 2 Diabetes in 2025 The anti-inflammatory and immunological properties

Youve likely heard about the incredible results of GLP-1 (glucagon-like peptide-1) medications, such as semaglutide, liraglutide, and tirzepatide, for

A key feature of the consensus is its endorsement of shared decision-making, taking into account patient goals, preferences, access, and affordability

Stanford Medicine clinicians explain why they have safety concerns, and what to do if you are taking one.

Previously we have shown that GLP-1 activates afferent renal nerve to increase efferent renal sympathetic nerve activity that negates the diuresis and natriuresis as a negative feedback mechanism in normal rats

Exposures Two cohorts were assembled, with the first composed of patients who started and continued on GLP-1 receptor agonists or DPP-4 inhibitors between 1 January 2007 and 31 December 2020 and the second composed of patients who started and continued on GLP-1 receptor agonists or SGLT-2 inhibitors between 1 January 1 2013 and 31 December 2020

Eat less, move more is not a long-term weight management solution